Advertisement

Surgery pp 2217-2232 | Cite as

Neurosurgery

  • Philip Starr

Abstract

The brain and spinal cord are bathed in 150mL cerebrospinal fluid (CSF), covered by three layers of connective tissue, the meninges, and encased in bone. The meninges, from innermost to outermost layers, consist of the pia mater, the arachnoid mater, and the dura mater. CSF is secreted mainly by the choroid plexus within the cerebral ventricles, flows through the ventricular system, and exits from the fourth ventricle into the subarachnoid space. Approximately 500 mL CSF is produced per day. CSF is absorbed into the venous system at the arachnoid granulations, which are specialized villi of the arachnoid membrane invaginating into the superior sagittal sinus.

Keywords

Cervical Spine Deep Brain Stim Head Trauma Disk Herniation Carpal Tunnel 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Guidelines for the management of severe head injury. Brain Trauma Foundation, American Association of Neurological Surgeons, Joint Section on Neurotrauma and Critical Care. J Neurotrauma 1996;13:641–734.CrossRefGoogle Scholar
  2. 2.
    Robertson CS, Valadka AB, Hannay HJ, et al. Prevention of secondary ischemic insults after severe head injury. Crit Care Med 1999;27:2086–2095.PubMedCrossRefGoogle Scholar
  3. 3.
    Juul N, Morris GF, Marshall SB, Marshall LF. Intracranial hypertension and cerebral perfusion pressure: influence on neurological deterioration and outcome in severe head injury. The Executive Committee of the International Selfotel Trial. J Neurosurg 2000;92:1–6.PubMedGoogle Scholar
  4. 4.
    Cruz J. The first decade of continuous monitoring of jugular bulb oxyhemoglobinsaturation: management strategies and clinical outcome. Crit Care Med 1998;26:344–351.PubMedCrossRefGoogle Scholar
  5. 5.
    Manley GT, Pitts LH, Morabito D, et al. Brain tissue oxygenation during hemorrhagic shock, resuscitation, and alterations in ventilation. J Trauma 1999;46:261–267.PubMedCrossRefGoogle Scholar
  6. 6.
    Allen CH, Ward JD. An evidence-based approach to management of increased intracranial pressure. Crit Care Clin 1998;14:485–495.PubMedCrossRefGoogle Scholar
  7. 7.
    Poungvarin N, Boopat W, Viriyavejakul A, et al. Effects of dexamethasone in primary supratentorial intracerebral hemmorhage. N Engl J Med 1987;316:1229–1233.PubMedGoogle Scholar
  8. 8.
    Braakman R, Schouten HJA, Dishoeck MB. Megadose steroids in severe head injury. J Neurosurg 1983;58:326–330.PubMedGoogle Scholar
  9. 9.
    Ayus JC, Krothapalli RK, Arieff A. Treatment of symptomatic hyponatremia and its relation to brain damage. N Engl J Med 1987;317:1190–1195.PubMedGoogle Scholar
  10. 10.
    Lazio BE, Simard JM. Anticoagulation in neurosurgical patients. Neurosurgery 1999;45:838–847; discussion 847–848.PubMedCrossRefGoogle Scholar
  11. 11.
    Hopf NJ, Grunert P, Fries G, Resch KD, Perneczcky A. Endoscopic third ventriculostomy: outcome analysis of 100 consecutive procedures. Neurosurgery 1999;44:795–804.PubMedCrossRefGoogle Scholar
  12. 12.
    Poon WS, Ng S, Wai S. CSF antibiotic prophylaxis for neurosurgical patients with ventriculostomy: a randomised study. Acta Neurochir Suppl (Wien) 1998;71:146–148.PubMedGoogle Scholar
  13. 13.
    Wong GK, Poon WS, Wai S, Yu LM, Lyon D, Lam JM. Failure of regular external ventricular drain exchange to reduce cerebrospinal fluid infection: result of a randomised controlled trial. J Neurol Neurosurg Psychiatry 2002;73:759–761.PubMedCrossRefGoogle Scholar
  14. 14.
    Pfausler B, Spiss H, Beer R, et al. Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: a prospective randomized trial of intravenous compared with intraventricular vancomycin therapy. J Neurosurg 2003;98:1040–1044.PubMedGoogle Scholar
  15. 15.
    Kestle JR. Pediatric hydrocephalus: current management. Neurol Clin 2003;21:883–895, vii.PubMedCrossRefGoogle Scholar
  16. 16.
    Schreffler RT, Schreffler AJ, Wittier RR. Treatment of cerebrospinal fluid shunt infections: a decision analysis. Pediatr Infect Dis J 2002;21:632–636.PubMedCrossRefGoogle Scholar
  17. 17.
    Ikata T, Iwasa K, Morimoto K, Tonai T, Taoka Y. Clinical considerations and biochemical basis of prognosis of cervical spinal cord injury. Spine 1989;14:1096–1101.PubMedCrossRefGoogle Scholar
  18. 18.
    Selden N, Quint D, Patel N, d’Arcy H, Papadopoulos S. Emergency magnetic resonance imaging of cervical spinal cordinjuries: clinical correlation and prognosis. Neurosurgery 1999;44:785–792.PubMedCrossRefGoogle Scholar
  19. 19.
    Denis F. The three column spine and its significance in the classification of acute thoracolumbar injuries. Spine 1983;8:817–831.PubMedCrossRefGoogle Scholar
  20. 20.
    Atkinson P, Atkinson J. Spinal shock. Mayo Clin Proc 1996;71:384–389.PubMedCrossRefGoogle Scholar
  21. 21.
    Takaoka M, Tabuse H, Kumura E, et al. Semiquantitative analysis of corpus callosum injury using magnetic resonance imaging indicates clinical severity in patients with diffuse axonal injury. J Neurol Neurosurg Psychiatry 2002;73:289–293.PubMedCrossRefGoogle Scholar
  22. 22.
    Keenan TL, Anthony J, Benson DR. Non-contiguous spinal fractures. J Trauma 1990;30:489–491.CrossRefGoogle Scholar
  23. 23.
    Widder S, Doig C, Burrowes P, Larsen G, Hurlbert RJ, Kortbeek JB. Prospective evaluation of computed tomographic scanning for the spinal clearance of obtunded trauma patients: preliminary results. J Trauma 2004;56:1179–1184.PubMedCrossRefGoogle Scholar
  24. 24.
    Cruz J, Minoja G, Okuchi K, Facco E. Successful use of the new high-dose mannitol treatment in patients with Glasgow Coma Scale scores of 3 and bilateral abnormal pupillary widening: a randomized trial. J Neurosurg 2004;100:376–383.PubMedGoogle Scholar
  25. 25.
    Friedman JA, Ebersold MJ, Quast LM. Post-traumatic cerebrospinal fluid leakage. World J Surg 2001;25:1062–1066.PubMedCrossRefGoogle Scholar
  26. 26.
    Temkin NR. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med 1990;323:497–502.PubMedGoogle Scholar
  27. 27.
    Meyer SH, Chestnut RM. Post-trauamatic extra-axial mass lesions: subdural and extradural hematoma. In: Tindall GT, Cooper PR, Barrow DL, eds. The Practice of Neurosurgery, vol 2. Baltimore: Williams & Wilkins, 1996:1443–1460.Google Scholar
  28. 28.
    Weiner HL, Cooper PR. Significance and management of cranial vault fractures. In: Tindall GT, Cooper PR, Barrow DL, eds. The Practice of Neurosurgery, vol 2. Baltimore: Williams & Wilkins, 1996:1541–1552.Google Scholar
  29. 29.
    Bracken MB, Shepard MJ, Collins WF. A randomized, controlled trial of methylprednisolone or nalozone in the treatment of acute spinal-cord injury. Results of the second national Acute Spinal Cord Injury Study. N Engl J Med 1990;322:1405–1411.PubMedGoogle Scholar
  30. 30.
    Bracken MB, Shepard MJ, Holford TR, et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA 1997;277:1597–1604.PubMedCrossRefGoogle Scholar
  31. 31.
    Bucholz RD, Cheung KC. Halo vest versus spinal fusion for cervical injury: evidence from an outcome study. J Neurosurg 1989;70:884–892.PubMedGoogle Scholar
  32. 32.
    Fritzell P, Hagg O, Jonsson D, Nordwall A. Cost-effectiveness of lumbar fusion and nonsurgical treatment for chronic low back pain in the Swedish Lumbar Spine Study: a multicenter, randomized, controlled trial from the Swedish Lumbar Spine Study Group. Spine 2004;29:421–434; discussion Z423.PubMedCrossRefGoogle Scholar
  33. 33.
    Fritzell P, Hagg O, Wessberg P, Nordwall A. 2001 Volvo Award Winner in Clinical Studies. Lumbar fusion versus nonsurgical treatment for chronic low back pain: a multicenter randomized controlled trial from the Swedish Lumbar Spine Study Group. Spine 2001;26:2521–2532; discussion 2532–2534.PubMedCrossRefGoogle Scholar
  34. 34.
    Wiebers DO, Whisnant JP, Sundt TM. The significance of unruptured intracranial saccular aneurysms. J Neurosurg 1987;66:23–29.PubMedGoogle Scholar
  35. 35.
    Hunt WE, Hess RM. Surgical risk as related to timing of intervention in the repair of intracranial aneurysms. J Neurosurg 1968;28:14–20.PubMedGoogle Scholar
  36. 36.
    Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemmorhage visualized by CT scanning. Neurosurgery 1980;6:1–9.PubMedCrossRefGoogle Scholar
  37. 37.
    Klopfenstein JD, Kim LJ, Feiz-Erfan I, et al. Comparison of rapid and gradual weaning from external ventricular drainage in patients with aneurysmal subarachnoid hemorrhage: a prospective randomized trial. J Neurosurg 2004;100:225–229.PubMedGoogle Scholar
  38. 38.
    Inagawa T, Kamiya K, Ogasawara H. Rebleeding of ruptured intracranial aneurysms in the acute stage. Surg Neurol 1987;28:93–99.PubMedCrossRefGoogle Scholar
  39. 39.
    Molyneux A, Kerr R, Stratton I, et al. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet 2002;360:1267–1274.PubMedCrossRefGoogle Scholar
  40. 40.
    Wanebo JE, Zabramski JM, Spetzler RF. Superficial temporal artery-to-middle cerebral artery bypass grafting for cerebral revascularization. Neurosurgery 2004;55:395–398; discussion 398–399.PubMedCrossRefGoogle Scholar
  41. 41.
    Laidlaw JD, Siu KH. Ultra-early surgery for aneurysmal subarachnoid hemorrhage: outcomes for a consecutive series of 391 patients not selected by grade or age. J Neurosurg 2002;97:250–258; discussion 247–259.PubMedCrossRefGoogle Scholar
  42. 42.
    Macdonald RL, Rosengart A, Huo D, Karrison T. Factors associated with the development of vasospasm after planned surgical treatment of aneurysmal subarachnoid hemorrhage. J Neurosurg 2003;99:644–652.PubMedGoogle Scholar
  43. 43.
    Treggiari MM, Walder B, Suter PM, Romand JA. Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. J Neurosurg 2003;98:978–984.PubMedGoogle Scholar
  44. 44.
    Andaluz N, Tomsick TA, Tew JM Jr, van Loveren HR, Yeh HS, Zuccarello M. Indications for endovascular therapy for refractory vasospasm after aneurysmal subarachnoid hemorrhage: experience at the University of Cincinnati. Surg Neurol 2002;58:131–138; discussion 138.PubMedCrossRefGoogle Scholar
  45. 45.
    Newell DW, Elliott JP, Eskridge JM, Winn HR. Endovascular therapy for aneurysmal vasospasm. Crit Care Clin 1999;15:685–699, v.PubMedCrossRefGoogle Scholar
  46. 46.
    Wiebers DO, Whisnant JP, Huston J III, et al. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 2003;362:103–110.PubMedCrossRefGoogle Scholar
  47. 47.
    Berger MS, Deliganis AV, Dobbins J, Keles GE. The effect of extent of resection on recurrence in patients with log grade hemisphere gliomas. Cancer (Phila) 1994;74:1784–1791.PubMedCrossRefGoogle Scholar
  48. 48.
    Albert FK, Forsting M, Sartor K, Adams HP, Kunze S. Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 1994;34:45–60.PubMedCrossRefGoogle Scholar
  49. 49.
    Vuorinen V, Hinkka S, Farkkila M, Jaaskelainen J. Debulking or biopsy of malignant glioma in elderly people: a randomised study. Acta Neurochir (Wien) 2003;145:5–10.CrossRefGoogle Scholar
  50. 50.
    Barnett GH, Kormos DW, Steiner CP, Weisenberger J. Intraoperative localization using an armless, frameless stereotactic wand. J Neurosurg 1993;78:510–514.PubMedGoogle Scholar
  51. 51.
    Black PM, Alexander E, Martin C, et al. Craniotomy for tumor treatment in an intraoperative magnetic resonance imaging unit. Neurosurgery 1999;45:423–433.PubMedCrossRefGoogle Scholar
  52. 52.
    Muacevic A, Kreth F, Horstmann GSE, et al. Surgery and radiotherapy compared with gamma knife radiosurgery in the treatment of solitary cerebral metastases of small diameter. J Neurosurg 1999;91:35–43.PubMedGoogle Scholar
  53. 53.
    Shrieve D, Alexander ER, Black P, et al. Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome. J Neurosurg 1999;90:72–77.PubMedGoogle Scholar
  54. 54.
    Kondziolka D, Lunsford LD, McLaughlin MR, Flickinger JC. Long-term outcomes after radiosurgery for acoustic neuromas. N Engl J Med 1998;339:1426–1433.PubMedCrossRefGoogle Scholar
  55. 55.
    Kondziolka D, Levy E, Niranjan A, Flickinger J, Lunsford L. Long-term outcomes after meningioma radiosurgery: physician and patient perspectives. J Neurosurg 1999;91:44–50.PubMedCrossRefGoogle Scholar
  56. 56.
    Nikolopoulos TP, O’Donoghue GM. Acoustic neuroma management: an evidence-based medicine approach. Otol Neurotol 2002;23:534–541.PubMedCrossRefGoogle Scholar
  57. 57.
    Valtonen S, Timonen U, Toivanen P, et al. Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double blind study. Neurosurgery 1997;41:44–48.PubMedCrossRefGoogle Scholar
  58. 58.
    Westphal M, Hilt DC, Bortey E, et al. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro-Oncology 2003;5:79–88.PubMedCrossRefGoogle Scholar
  59. 59.
    Van Meir EG, Bellail A, Phuphanich S. Emerging molecular therapies for brain tumors. Semin Oncol 2004;31:38–46.PubMedGoogle Scholar
  60. 60.
    Cohen LM, Germain MJ, Poppel DM. Practical considerations in dialysis withdrawal. JAMA 2003;289:2113–2119.PubMedCrossRefGoogle Scholar
  61. 61.
    Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 1990;249:1436–1438.PubMedCrossRefGoogle Scholar
  62. 62.
    Freed CR, Greene PE, Breeze RE, et al. Transplantation of embryonic dopamine neurons for severe Parkinson’s disease. N Engl J Med 2001;344:710–719.PubMedCrossRefGoogle Scholar
  63. 63.
    Olanow CW, Goetz CG, Kordower JH, et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson’s disease. Ann Neurol 2003;54:403–414.PubMedCrossRefGoogle Scholar
  64. 64.
    Smith HP, McWhorter JM, Armstrong D, Johnson R, Transou C, Howard G. Comparision of mannitol regimens in patients with severe head injury undergoing intracranial pressure monitoring. J Neurosurg 1986;65:820–824.PubMedGoogle Scholar
  65. 65.
    Muizelaar JP, Marmarou A, Ward JD, et al. Adverse effects of prolonged hyperventilation in patients with severe head injury. J Neurosurg 1991;75:731–739.PubMedCrossRefGoogle Scholar
  66. 66.
    Ward JD, Becker DP, Miller JD, et al. Failure of prophylactic barbiturate coma in the treatment of severe head injury. J Neurosurg 1985;62:383–388.PubMedGoogle Scholar
  67. 67.
    Eisenberg HM, Frankowski RF, Constant CF, et al. High-dose barbiturate control of elevated intracranial pressure in patients with severe head injury. J Neurosurg 1988;69:15–23.PubMedGoogle Scholar
  68. 68.
    Clifton GL, Allen S, Barrodale P, et al. A phase II study of moderate hypothermia in severe brain injury. J Neurotrauma 1993;10:263–271; discussion 273.PubMedCrossRefGoogle Scholar
  69. 69.
    Teasdale G, Jennett B. Assessment of coma and impaired consciousness: a practical scale. Lancet 1974;2:81–84.PubMedCrossRefGoogle Scholar
  70. 70.
    Wiebe S, Blume WT, Girvin JP, Eliasziw M. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med 2001;345:311–318.PubMedCrossRefGoogle Scholar
  71. 71.
    North RB, Kidd DH, Piantadosi S. Spinal cord stimulation versus reoperation for failed back surgery syndrome: a prospective, randomized study design. Acta Neurochir Suppl (Wien) 1995;64:106–108.PubMedGoogle Scholar
  72. 72.
    Vitek JL, Bakay RA, Freeman A, et al. Randomized trial of pallidotomy versus medical therapy for Parkinson’s disease. Ann Neurol 2003;53:558–569.PubMedCrossRefGoogle Scholar
  73. 73.
    de Bie RM, de Haan RJ, Nijssen PC, et al. Unilateral pallidotomy in Parkinson’s disease: a randomised, single-blind, multicentre trial. Lancet 1999;354:1665–1669.PubMedCrossRefGoogle Scholar
  74. 74.
    Schuurman PR, Bosch DA, Bossuyt PM, et al. A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med 2000;342:461–468.PubMedCrossRefGoogle Scholar
  75. 75.
    Esselink RA, de Bie RM, de Haan RJ, et al. Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: a randomized trial. Neurology 2004;62:201–207.PubMedGoogle Scholar
  76. 76.
    Nutt JG, Burchiel KJ, Cornelia CL, et al. Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology 2003;60:69–73.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Philip Starr
    • 1
    • 2
  1. 1.Functional Neurosurgery Program, Department of Neurological SurgeryUniversity of California, San FranciscoSan FranciscoUSA
  2. 2.Parkinson’s Disease ResearchEducation and Care Center (PADRECC) at San Francisco Veteran’s Affairs Medical CenterSan FranciscoUSA

Personalised recommendations